TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 303 filers reported holding TANDEM DIABETES CARE INC in Q2 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $330,529 | -39.5% | 13,469 | +0.0% | 0.16% | -43.1% |
Q1 2023 | $546,773 | +89977.9% | 13,464 | -0.4% | 0.27% | -11.9% |
Q4 2022 | $607 | -99.9% | 13,512 | -0.7% | 0.31% | -12.9% |
Q3 2022 | $651,000 | -16.3% | 13,608 | +3.5% | 0.36% | -13.3% |
Q2 2022 | $778,000 | -49.2% | 13,148 | -0.2% | 0.41% | -42.5% |
Q1 2022 | $1,532,000 | -23.1% | 13,171 | -0.5% | 0.72% | -12.8% |
Q4 2021 | $1,992,000 | -13.7% | 13,235 | -31.6% | 0.82% | -21.6% |
Q3 2021 | $2,308,000 | -3.2% | 19,336 | -21.0% | 1.05% | +28.8% |
Q2 2021 | $2,385,000 | +6.9% | 24,484 | -3.2% | 0.81% | +9.9% |
Q1 2021 | $2,232,000 | -8.7% | 25,294 | -1.0% | 0.74% | -20.3% |
Q4 2020 | $2,445,000 | -16.6% | 25,555 | -1.0% | 0.93% | -33.7% |
Q3 2020 | $2,931,000 | +4.6% | 25,821 | -8.8% | 1.40% | +8.9% |
Q2 2020 | $2,802,000 | +33.4% | 28,324 | -13.2% | 1.28% | +26.4% |
Q1 2020 | $2,101,000 | +23.8% | 32,647 | +14.7% | 1.02% | +45.7% |
Q4 2019 | $1,697,000 | – | 28,469 | – | 0.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 1,000,000 | $59,610,000 | 47.04% |
Prospect Capital Advisors, LLC | 127,900 | $7,624,000 | 4.68% |
Asymmetry Capital Management, L.P. | 43,559 | $2,597,000 | 4.66% |
Copernicus Capital Management, LLC | 50,000 | $2,981,000 | 3.91% |
SECTORAL ASSET MANAGEMENT INC | 341,714 | $20,370,000 | 3.04% |
FRIESS ASSOCIATES LLC | 627,225 | $37,389,000 | 2.60% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,361,345 | $81,150,000 | 2.59% |
Parkman Healthcare Partners LLC | 134,959 | $8,045,000 | 2.32% |
OBERWEIS ASSET MANAGEMENT INC/ | 109,940 | $6,554,000 | 2.18% |
First Light Asset Management, LLC | 268,574 | $16,010,000 | 2.05% |